News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yan Leyfman Welcomed Markus Mapara as Keynote Speaker on the Future of Curative Therapy in Sickle Cell Disease
Yan Leyfman and Markus Mapara
Jun 17, 2025, 07:35

Yan Leyfman Welcomed Markus Mapara as Keynote Speaker on the Future of Curative Therapy in Sickle Cell Disease

Yan Leyfman, Co-founder and Executive Director of MedNews Week, posted on X:

“MedNews Week KEYNOTE Conference
We’re honored to welcome Dr. Markus Mapara, world-renowned leader in transplantation and cell therapy, as our next MedNews Week x OncLive Keynote Speaker!
Professor of Medicine at Columbia University Irving Medical Center, Director, Bone Marrow Transplantation and Cell Therapy Program, Columbia University Vagelos College of Physicians and Surgeons.
Dr. Mapara will spotlight the future of curative therapy in sickle cell disease, diving into the promise of allogeneic transplant and gene therapy.
This is a must-watch for anyone interested in cutting-edge hematology and breakthroughs in patient care! 
Catch the presentation.”

Markus Mapara

More posts featuring Yan Leyfman on OncoDaily.

cancer Cell Therapy Columbia University Irving Medical Center Columbia University Vagelos College of Physicians and Surgeons MedNews Week OncoDaily Oncology sickle cell disease Yan Leyfman
Special Coverage
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference
Science
Aug 18, 2025, 16:33
Maria Tolia: New Study on Cardio-Oncology Considerations for Breast Cancer